Document Detail

Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
MedLine Citation:
PMID:  23289539     Owner:  NLM     Status:  Publisher    
BACKGROUND: Enterocyte damage is the hallmark of coeliac disease (CD) resulting in malabsorption. Little is known about the recovery of enterocyte damage and its clinical consequences. Serum intestinal fatty acid binding protein (I-FABP) is a sensitive marker to study enterocyte damage. AIMS: To evaluate the severity of enterocyte damage in adult-onset CD and its course upon a gluten-free diet (GFD). Furthermore, the correlation among enterocyte damage, CD autoantibodies and histological abnormalities during the course of disease is studied. METHODS: Serum I-FABP levels were determined in 96 biopsy-proven adult CD patients and in 69 patients repeatedly upon a GFD. A total of 141 individuals with normal antitissue transglutaminase antibody (IgA-tTG) levels served as controls. I-FABP levels were related to the degree of villous atrophy (Marsh grade) and IgA-tTG. RESULTS: I-FABP levels were elevated in untreated CD (median 691 pg/mL) compared with controls (median 178 pg/mL, P < 0.001) and correlated with Marsh grade (r = 0.265, P < 0.05) and IgA-tTG (r = 0.403, P < 0.01). Upon a GFD serum levels decreased significantly, however, not within the range observed in controls, despite the common observed normalisation of IgA-tTG levels and Marsh grade. CD patients with elevated I-FABP levels nonresponding to GFD showed persistent histological abnormalities. CONCLUSIONS: Enterocyte damage assessed by serum I-FABP correlates with the severity of villous atrophy in coeliac disease at the time of diagnosis. Although enterocyte damage improves upon treatment, substantial enterocyte damage persists despite absence of villous atrophy and low IgA-tTG levels in the majority of cases. Elevated I-FABP levels nonresponding to gluten-free diet are indicative of histological abnormalities and warrant further evaluation.
M P M Adriaanse; G J Tack; V Lima Passos; J G M C Damoiseaux; M W J Schreurs; K van Wijck; R G Riedl; A A M Masclee; W A Buurman; C J J Mulder; A C E Vreugdenhil
Related Documents :
24115389 - Do cortisol and corticosterone play the same role in coping with stressors? measuring g...
23848039 - Significance of copper level in serum and routine laboratory parameters in estimation o...
23790719 - The effect of dioestrus on the racing performance of greyhounds.
23921169 - Antimicrobial impact of cold atmospheric pressure plasma on medical critical yeasts and...
23955409 - Changes in haematology, plasma biochemistry and erythrocyte osmotic fragility of the ni...
24807379 - Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of r...
22444289 - Effects of restricted nursing on milk production and collection, kid growth and plasma ...
9274709 - Corticotrophic macroadenoma of the pituitary associated with hypoadrenalism.
7428159 - Improved ultrafiltration method for determining unbound cortisol in plasma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-7
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  -     ISSN:  1365-2036     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 Blackwell Publishing Ltd.
Department of Paediatrics & Nutrition and Toxicology Research Institute Maastricht (NUTRIM), Maastricht University Medical Centre, Maastricht, the Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interfacial chemistry in Al/CuO reactive nanomaterial and its role in exothermic reaction.
Next Document:  Allosteric inhibition of VIM metallo-?-lactamases by a camelid nanobody.